25021-237 : Fludarabine Phosphate 25 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC25021-237
Labeler: Sagent Pharmaceuticals
Product Type: Human Prescription Drug
Drug Name: Fludarabine Phosphate
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA076349
Rev. Date: 


NDC Package Codes:

  • 25021-237-06: 1 VIAL IN 1 CARTON (25021‑237‑06) > 2 ML IN 1 VIAL

Active Ingredients:

  • Fludarabine Phosphate

Dosage Strength:

  • 25 mg/mL

Pharmaceutical Classes:

  • Nucleic Acid Synthesis Inhibitors [MoA]
  • Nucleoside Metabolic Inhibitor [EPC]

Related Products:

Based on records with the same trade name.
  • 25021-242 Fludarabine Phosphate 25 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • 25021-205 Fludarabine Phosphate 50 mg/2ml Intravenous Injection by Sagent Pharmaceutical, Inc.
  • 0069-9321 Fludarabine Phosphate 25 mg/ml Intravenous Injection by Pfizer Laboratories Div Pfizer Inc.
  • 0703-4852 Fludarabine Phosphate 25 mg/ml Intravenous Injection by Teva Parenteral Medicines, Inc.
  • 0703-5854 Fludarabine Phosphate 50 mg/2ml Intravenous Injection, Powder, Lyophilized, for Solution by Teva Parenteral Medicines, Inc.
  • 24201-237 Fludarabine Phosphate 25 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Leucadia Pharmaceuticals
  • 45414-311 Fludarabine Phosphate 10 mg Oral Tablet by Antisoma Research Limited
  • 45963-609 Fludarabine Phosphate 50 mg/2ml Intravenous Injection, Powder, Lyophilized, for Solution by Actavis Pharma, Inc.
  • 45963-621 Fludarabine Phosphate 25 mg/ml Intravenous Injection, Solution by Actavis Pharma, Inc.
  • 61703-344 Fludarabine Phosphate 50 mg/2ml Intravenous Injection, Powder, Lyophilized, for Solution by Hospira Worldwide, Inc.
  • 66758-046 Fludarabine Phosphate 25 mg/ml Intravenous Injection, Solution by Sandoz Inc
  • 67457-238 Fludarabine Phosphate 25 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
  • 67457-268 Fludarabine Phosphate 25 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
  • 67457-495 Fludarabine Phosphate 25 mg/ml Intravenous Injection by Mylan Institutional LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 25021-237 QR Code

< Prev: 25021-236Next: 25021-239 >

Related Discussions:

Codeine Phosphate 30g
can you tell me how many of these tablets would result in an overdose? ## There is really no definitive answer to such a... 3 replies
codeine phosphate
little white tablrt t ## Can anyone tell me if Codeine Phosphate 30 mg tablets will relieve the pain that a percocet 10/... 2 replies
codeine phosphate clorphenramine syrup
I am taking codeine syrup taking 100 ml in a day. What are its side effects and how should I go about the withdrawal pro... 1 reply
codiene phosphate dpi
red and white capsule imprint dpi 364 ## Based on the description provided, I found your pill to be Duradrin; which is a... 1 reply
Codeine Phosphate Ta 30mg Cod
is it ok to drink alcohol whilst taking codeine phosphate 30mg 4 times a day ## It is not recommended that you use alcoh... 1 reply
sitagliptin phosphate metformin hydrochloride tablet
Sitagliptin phosphate mrtoformin hydrochloride istamet tablet should be takeb before or after food ## Unless your doctor... 1 reply
clindamycin phosphate gel expiration date
Hello, I have a 1 year old clindamycin phosphate gel tube that I am considering using. My acne is acting up and I would ... 1 reply
chloroquine phosphate
Arthritis ## Chloroquine phosphate has long been used in the treatment or prevention of malaria. As it mildly suppresses... 1 reply
Is clindamycin phosphate lotion1% safe to use on a 13 lb dog
My bichon has red on the inside of his ears and a hot spot below his ear another hot spot on his neck. I put this lotion... 3 replies
taking codeine phosphate to help come off subutex
Hi, I was prescribed 180mg of codeine phosphate for on-going back pain, BUT I decided to give subutex a go, as advised b... 1 reply




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2015.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA